Growth Metrics

Eli Lilly (LLY) Dividends payables Growth (3y) (2012 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 15.10%
Dec 31, 2024 14.99%
Jun 30, 2024 14.94%
Dec 31, 2023 14.91%
Dec 31, 2022 14.85%
Jun 30, 2022 14.10%
Dec 31, 2021 10.81%
Jun 30, 2021 10.06%
Dec 31, 2020 9.27%
Dec 31, 2019 7.00%
Jun 30, 2019 3.38%
Dec 31, 2018 6.48%
Jun 30, 2018 3.00%
Dec 31, 2017 3.66%
Jun 30, 2017 1.47%
Dec 31, 2016 1.54%
Jun 30, 2016 0.66%
Dec 31, 2015 -0.15%
Jun 30, 2015 -0.89%
Dec 31, 2014 -0.74%
Jun 30, 2014 -1.13%
Dec 31, 2013 -1.03%
Jun 30, 2013 -1.16%
Dec 31, 2012 0.21%
Jun 30, 2012 0.35%